Diagnostic imaging company Bracco Imaging is partnering with AI image acquisition developer Subtle Medical to integrate their technologies in an effort to advance the use of contrast-enhanced MRI around the world.

The global agreement will begin mainly in the U.S., where Bracco Imaging distributes its portfolio of products and services through its subsidiary, Bracco Diagnostics.

The companies said that investigating AI's potential in contrast-enhanced MRI could lead to more accurate and efficient image interpretation, improved diagnostic capabilities, and best practices for patient care.